Markets:

Overview

News

Currencies

International

Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

18.72 +0.06 (+0.32%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

3 Things About Johnson & Johnson That Smart Investors Know ↗

September 27, 2023

J&J shares have missed out on the market rally so far this year.

Via The Motley Fool

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE

September 26, 2023

WHY: NEW YORK, NY - (NewMediaWire) - September 25, 2023 - Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of...

Via TheNewswire.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE

September 25, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

3 Best Stocks to Buy in September and Hold Forever ↗

September 24, 2023

Healthcare blue chip stocks with proven track records can be excellent long-term investments.

Via The Motley Fool

3 Reasons SharkNinja Is Swimming Toward New Highs

September 22, 2023

Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders.

Via MarketBeat

Check Out What Whales Are Doing With KVUE ↗

September 19, 2023

Via Benzinga

Looking Into Kenvue's Recent Short Interest ↗

September 18, 2023

Via Benzinga

Kenvue Unusual Options Activity For September 13 ↗

September 13, 2023

Via Benzinga

Kenvue to Announce Third Quarter 2023 Results on October 26, 2023

September 22, 2023

From Kenvue Inc.

Via Business Wire

KVUE INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation – KVUE

September 21, 2023

From Rosen Law Firm

Via Business Wire

2 Incredibly Cheap Dividend Stocks to Buy Now ↗

September 20, 2023

High-quality dividend stocks are rarely cheap. These two names are an exception.

Via The Motley Fool

7 Safe and Steady Dividend Stocks to Buy for Volatile Time ↗

September 19, 2023

Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape.

Via InvestorPlace

3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income ↗

September 17, 2023

These companies generate durable and growing cash flows.

Via The Motley Fool

Better Buy: J&J vs. Kenvue ↗

September 13, 2023

You can count on both of these companies for passive income, too.

Via The Motley Fool

Analyst Ratings for Kenvue ↗

September 11, 2023

Via Benzinga

Kenvue Unusual Options Activity ↗

September 07, 2023

Via Benzinga

Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year ↗

September 15, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money.

Via Benzinga

3 Great Dividend Stocks You Can Buy for Less Than $50 ↗

September 15, 2023

These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.

Via The Motley Fool

3 Blue-Chip Stocks to Watch in the ‘Green Zone’ ↗

September 14, 2023

Now may be the time to take a look at these three blue-chips, as each one is currently in the "Green Zone stocks" category.

Via InvestorPlace

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗

September 12, 2023

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...

Via Benzinga

Is J&J a Buy After the Kenvue Separation? ↗

September 06, 2023

J&J shares have been on the decline.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023 ↗

September 11, 2023

Via Benzinga

Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip ↗

September 10, 2023

The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.

Via The Motley Fool

Topics Stocks

The 7 Best Dow Stocks to Buy Now: September 2023 ↗

September 08, 2023

These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market.

Via InvestorPlace

Topics Stocks

J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block

September 07, 2023

Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion.

Via MarketBeat

Topics ETFs

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗

September 07, 2023

Via Benzinga

1 Brand-New Dividend Stock Income Investors Won't Want to Miss ↗

September 07, 2023

The recently spun-off Kenvue looks to be a high-quality dividend stock.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories ↗

September 05, 2023

Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users?

Via Benzinga

Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation ↗

September 05, 2023

Johnson & Johnson (NYSE: JNJ) is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc (NYSE: KVUE) to bolster its growth in

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Kenvue Inc. Common Stock (NY:KVUE)

All News about Kenvue Inc. Common Stock

Starting at $3.75/week.

Subscribe Today